Sector: MedicalInterlott Technologies, Inc. (AMEX: ILI)
Headlines
- Interleukin Genetics Reports Third Quarter 2009 Financial Results
Nov 12, 2009 04:20 PM | ILI
- Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 Results
Nov 05, 2009 07:02 AM | ILI
- Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic Tests
Oct 29, 2009 07:02 AM | ILI
- Interleukin Genetics to Present Research Findings at Upcoming Medical Meetings
Oct 13, 2009 07:01 AM | ILI
- ILI Technologies Appoints New Director and Chief Executive Officer
Sep 30, 2009 06:02 PM | ILI
- Stocks To Try For Gains Early - More Policy Clues From Fed Desired
Sep 23, 2009 09:22 AM | F, ILI, QTWW
- Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight Loss
Sep 23, 2009 07:01 AM | ILI
- ILI Technologies Appoints New Director
Jul 08, 2009 02:07 PM | ILI
- ILI Technologies (2002) Corp. Announces that it is Undertaking a $1,000,000.00 Private Placement of 10,000,000 Units of the Corporation.
Mar 31, 2009 07:52 PM | ILI
- ILI Technologies Announces the Issuance of Options to its Chief Financial Officer
Mar 02, 2009 05:35 PM | ILI
- Interleukin Genetics Reports Second Quarter 2009 Financial Results
Aug 13, 2009 04:54 PM | ILI
- Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
Aug 06, 2009 07:30 AM | ILI
- Third Rock Ventures Expands Team With Biotech Veterans
Jul 21, 2009 10:02 AM | CBST, ILI, VRTX
- Interleukin Genetics Announces Strategic Divestment of Alan James Group
Jul 02, 2009 07:01 AM | ILI
- Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to Wellness
Jun 08, 2009 09:05 AM | ILI
- Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting
Jun 05, 2009 02:01 PM | ILI
- Interleukin Genetics to Present at the 2009 BIO Business Forum
May 15, 2009 09:00 AM | ILI
- Interleukin Genetics Reports First Quarter 2009 Financial Results
May 14, 2009 04:00 PM | ILI
- NYSE Amex Accepts Interleukin Genetics' Plan to Meet Continued Listing Standards
May 14, 2009 08:17 AM | ILI
- Interleukin Genetics to Chair Expert Panel Discussion on Use of Biomarkers in Drug Development at BIO Convention
May 12, 2009 07:31 AM | ILI
- Form 4 KORNMAN KENNETH S For: Mar 31 (10K)
Apr 01, 2009 04:54 PM
- Form 4 Lurier Eliot M For: Mar 13 (10K)
Mar 16, 2009 06:48 PM
- Form 4 Lurier Eliot M For: Nov 24 (10K)
Nov 25, 2008 02:46 PM
- Form 4 BENDER LEWIS H For: Nov 21 (10K)
Nov 24, 2008 06:58 PM
- Form 4 CHOWNING MARY E For: Nov 20 (10K)
Nov 24, 2008 04:36 PM
- Form 4 BENDER LEWIS H For: Nov 18 (10K)
Nov 20, 2008 09:19 PM
- Form 4 KORNMAN KENNETH S For: Nov 18 (10K)
Nov 20, 2008 05:47 PM
- Form 4 KORNMAN KENNETH S For: Nov 12 (10K)
Nov 14, 2008 12:19 PM
- Form 4 CHOWNING MARY E For: Jul 24 (10K)
Jul 28, 2008 05:03 PM
- Form 3 CHOWNING MARY E For: Jul 24 (10K)
Jul 28, 2008 05:02 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
ILI
|
Compare to S&P
|
| YTD |
324.95 %
|
251.66 %
|
| 4 Weeks |
-7.62 %
|
-12.30 %
|
| 12 Weeks |
80.79 %
|
68.35 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -14.29 %
|
|
EPS Growth in Last Year: -60.00 %
|
|
Sales Growth in Last Quarter: 44.84 %
|
|
Sales Growth in Last Quarter: -85.13 %
|
|
